Interim Results
Bci Navigation
€1.11
16:30 01/09/22
IMMEDIATE RELEASE Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 24 September 2024
A.G. BARR p.l.c.
("A.G. BARR")
Â
A.G. BARR p.l.c., the branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.
INTERIM RESULTS FOR THE 26 WEEKS ENDED 27 JULY 2024
Strong H1 growth in revenue and operating profit, with operating margin expansion, underpins delivery of full year expectations
Â
Financial summary
26 wks to 27 July 2024 | 26 wks to 30 July 2023 | Change | ||
Revenue | £221.3m | £210.4m | 5.2% | |
Profit before tax (adjusted)* | £29.3m | £27.0m | 8.5% | |
Operating margin (adjusted)* | 13.0% | 12.5% | 50 bps | |
Profit before tax | £24.9m | £27.8m | (10.4%) | |
Basic EPS | 16.88p | 18.87p | (10.5%) | |
Basic EPS (adjusted)* | 19.86p | 18.15p | 9.4% | |
Interim dividend per share | 3.10p | 2.65p | 17.0% | |
Net cash at bank* | £43.7m | £47.3m | (7.6%) |
* Items marked with an asterisk are non-GAAP measures. Â Definitions and relevant reconciliations are provided at the end of this announcement
Highlights
â—‹Â Â Â Total revenue growth of 5.2%, driven by Soft Drinks up 7.0%, with Rubicon and IRN-BRU delivering both volume and price gains
○   A strong H1 profit performance from successfully executing a clear and consistent strategy. Profit before tax (adjusted)* up 8.5%
○   Profit before tax of £24.9m is after £4.4m of one-off costs related to the closure of Barr Direct and the integration of Boost
â—‹Â Â Â Operating margin (adjusted)* up 50 bps demonstrating further progress with the margin rebuild programme, with continued benefit anticipated in H2
○   Net cash at bank* of £43.7m, down from £47.3m due to successful acquisition of Rio in October 23, along with significant availability on committed debt facilities to support future growth
â—‹Â Â Â Interim dividend of 3.10 pence per share representing an increase on the prior year of 17.0%
Â
Euan Sutherland, Chief Executive, commented:
"My first few months with the business has further cemented my view that AG Barr is an excellent business with exciting, tangible and deliverable growth opportunities. I am pleased to report a strong set of first half results. The business has delivered both revenue and profit growth as well as good progress on our key strategic margin rebuild programme.
We continue to invest in our supply chain to build the capacity to support our growth plans and manufacture more volume in-house. This will deliver tangible benefits including enhanced margin and improved service resilience.
We anticipate a strong H2 performance from our four core brands - IRN-BRU, Rubicon, Boost and FUNKIN - in particular, with current trading momentum underpinned by further marketing and innovation activities.Â
Guidance on 2024/25 revenue and operating margin is unchanged. We remain confident of continued, sustainable growth over the long term, in line with our strategic ambitions."
Â
For more information, please contact:
A.G. BARR 0330 390 3900                                Instinctif Partners 020 7457 2020
Euan Sutherland, Chief Executive                                  Justine Warren
Stuart Lorimer, Finance Director                                     Matthew Smallwood
_______________________________________________________________________________
Interim statement
We are pleased to report a strong H1 performance through execution of our clear and consistent growth strategy of building brands that people love.
Revenue increased 5.2% to £221.3m and operating margin (adjusted)* improved by 50 bps to 13.0%. This delivered profit before tax (adjusted)* growth of 8.5% to £29.3m.
Particularly pleasing was the performance of our Soft Drinks business where revenue increased 7.0%, driven by both volume and price. Rubicon was the stand out performer, delivering double digit growth in both volume and value.
Profit before tax of £24.9m included a non-recurring (£4.4m) adjusting item related to the business change projects involving the closure of Barr Direct and the integration of the Boost business.
These key projects progressed to plan in H1. The Barr Direct route to market closed at the end of June with no impact to customer service. Symbol and Independent retailers are now fully serviced through the wholesale route to market, supported by a larger in-house Field Sales team. The integration of the Boost business, acquired in 2022, is on track and will be completed during H2. Our expectation of the payback from these two projects remains less than 2 years. Manufacturing synergies continue to be realised as production is insourced in line with our plan. Â
Market context
Soft drinks:
The UK soft drinks market was up 2.0% versus the same period in the prior year. Growth was price led with volumes marginally down (0.4%), partly as a consequence of the disappointing early summer weather. Whilst value was up, the level of price inflation in the market has reduced significantly versus the peak in 2023. Overall, our performance was ahead of the market across both volume and value, with growth primarily arising in segments not measured by market analytic data.
(Source : Circana data for the 26 weeks to 27 July 2024)
Cocktails:
Ready to drink (RTD) cocktails in the take home market grew 9.1%, well ahead of the wider pre-mixed alcoholic drinks market growth rate of 2.7%. FUNKIN's growth was ahead of both market segments and it remains the number one brand in the RTD cocktail market.
As has been widely documented, the UK on-trade market continued to experience challenging trading conditions during the period. The value of cocktails in the on-trade declined by (1.3%) in the year to March 2024 driven primarily by a (1.9%) reduction in the number of outlets. Cocktails performed relatively favourably within this wider trend, marginally growing volume share. Whilst we expect on-trade cocktail consumption to return to growth in the longer term, this may take some time given current economic and consumer trends.
(Source: Nielsen pre-mixed alcoholic drinks total coverage YTD 13/07/2024; CGA Q1 2024)
Business performance
Overall revenue growth of 5.2% driven by Soft drinks performance.
Revenue (£m) | Change vs H1 2023/24 (%) | |
Soft drinks | £194.6m | 7.0% |
Cocktail solutions (FUNKIN) | £21.1m | (9.4%) |
Other (MOMA) | £5.6m | 7.7% |
Â
7.0% growth in Soft Drinks revenue was led by Rubicon, which continued to grow ahead of the market through distribution gains and an increase in marketing investment. Revenue from IRN-BRU was up through a combination of volume and value growth, with a highly effective Euros marketing campaign and continued market share gains in England. The focus for Boost this year is on margin improvement, including profit recovery and insourcing of production. This is progressing in line with plan. Our soft drinks business carried good momentum into H2 and we expect further growth in the second half supported by our promotional and marketing investment plans.
FUNKIN experienced a challenging H1 with revenue down (9.4%). The key driver of this decline was on-going weak consumer demand in the on-trade channel where late night venues remained particularly affected. More positively, the FUNKIN ready-to-drink (RTD) business has continued to grow at pace in the strategic growth channel of retail despite revenue in H1 being impacted by a short term issue with third party can production which impacted sales to retailers but is now resolved. With a more resilient supply chain now in place and an exciting innovation pipeline we expect FUNKIN to perform positively in H2.
MOMA maintained its growth in H1 with new distribution gains. We expect MOMA's growth to accelerate in H2 through further range development.
Cash flow and balance sheet
Net cash from operating activities of £13.0m was £2.1m below the prior year (2023/24 H1: £15.1m). This was primarily driven by the non-recurring costs associated with the business change projects.Â
We have managed working capital effectively across H1. We collected cash in a timely manner from our customers and had no significant unrecoverable debt during the period. Inventory levels have generally been good albeit we experienced a small number of specific issues with third party suppliers which temporarily reduced inventory below desired levels and are now resolved.
Capital expenditure* in H1 was £7.4m (2023/24 H1: £6.5m). As in the prior year, our plan sees higher capital expenditure expected in the second half of the year due to the timing of specific activities. During H1 the key project completed was the installation and commissioning of a new small PET line in Cumbernauld, which provides increased manufacturing capability and resilience for the long term. The Cumbernauld factory asset refresh programme remains on track, and is expected to be completed by January 2026. Full year capital expenditure* in the current year is estimated at c.£20m (2023/24: £17.8m), with H2 expenditure concentrated on investment in Cumbernauld and Milton Keynes manufacturing lines.
The business closed the period with net cash at bank* of £43.7m. This was £3.6m lower than the Interim reporting date in the prior year, principally owing to the £12.3m cash outflow in acquiring Rio in October 2023. The closing net cash at bank* balance was £9.9m less than the period opening position (£53.6m) due to the normal funding of dividend, tax and capital expenditure, alongside the seasonal demands for higher working capital during the summer trading period. We expect our cash balance to increase in H2 as it has historically.
Board
As previously communicated, after 20 years, Jonathan Kemp stepped down from the Board in May and will retire from his position as Commercial Director at the end of September 2024. Jonathan will remain with the company until September 2025 to lead a number of projects and support a smooth transition.Â
We are pleased to announce the appointment of Dino Labbate. Dino joins in January 2025 from Britvic, in a newly created, broader role of MD A.G. BARR, reporting to the CEO.
The transition of CEO is now complete and has been executed successfully without any disruption to the business. Looking forward, the senior leadership team is fully focused on delivering the business' strategy and accelerating its growth trajectory.
Dividend
The Board has declared an interim dividend for the 26 weeks ended 27 July 2024 of 3.10 pence per share (2023/24: 2.65 pence) payable on 1 November 2024 to shareholders on the register on 4 October 2024. This is in line with our policy of the interim dividend being 25% of the prior final year dividend. Â
Outlook
The positive H1 performance was in line with our expectations and we have ambitious plans for H2 and beyond, which are consistent with our long term growth strategy. We will continue to invest behind our brands to drive revenue growth, and continue to progress our strategic project agenda to deliver margin improvement and strengthen our supply base. We remain conscious of the current pressure on consumers and will be responsive to changes in the dynamic markets in which we operate. We are confident that, assuming a reasonably settled external environment, the execution of our plans will result in a strong H2 and the delivery of a full year performance in line with current market expectations**.
Â
Mark Allen                                                                Euan Sutherland
Chairman                                                                   Chief Executive
Â
** Analyst consensus: FY24/25 Net Revenue £421.5m, PBT £57.2m (FY23/24 PBT £50.5m)
Â
Â
Consolidated Condensed Income Statement | Â | ||||||
 | Unaudited |  | Unaudited | Audited | |||
Six months ended 27 July 2024 | Â | Six months ended 30 July 2023 | Year ended 28 January 2024 | ||||
Note | £m |  | £m | £m | |||
Revenue | 6 | 221.3 | Â | 210.4 | 400.0 | ||
Cost of sales | (132.2) | Â | (131.0) | (245.8) | |||
Gross profit | 6 | 89.1 | Â | 79.4 | 154.2 | ||
Operating expenses | (64.8) | Â | (52.2) | (104.1) | |||
Operating profit | 8 | 24.3 | Â | 27.2 | 50.1 | ||
Finance income | 9 | 0.8 | Â | 0.7 | 1.4 | ||
Finance costs | 9 | (0.2) | Â | (0.1) | (0.2) | ||
Profit before tax | 24.9 | Â | 27.8 | 51.3 | |||
Tax on profit | 10 | (6.2) | Â | (6.8) | (12.8) | ||
Profit attributable to equity holders | 18.7 | Â | 21.0 | 38.5 | |||
Earnings per share (pence) | Â | ||||||
Basic earnings per share | 11 | 16.88 | Â | 18.87 | 34.59 | ||
Diluted earnings per share | 11 | 16.72 | Â | 18.67 | 34.24 | ||
Â
Â
Consolidated Condensed Statement of Financial Position | ||||
 | Unaudited | Unaudited | Audited | |
As at 27 July 2024 | As at 30 July 2023 | As at 28 January 2024 | ||
Note | £m | £m | £m | |
Non-current assets | ||||
Intangible assets | 129.9 | 115.6 | 130.4 | |
Property, plant and equipment | 107.8 | 102.2 | 109.0 | |
Right-of-use assets | 4.6 | 5.2 | 5.2 | |
Retirement benefit surplus | 17 | 6.2 | 3.2 | 3.2 |
248.5 | 226.2 | 247.8 | ||
Current assets | Â | |||
Inventories | 35.6 | 36.0 | 36.5 | |
Trade and other receivables | 94.1 | 93.9 | 63.8 | |
Assets classified as held for sale | 13 | 2.1 | - | - |
Current tax asset | 0.2 | - | - | |
Short-term investments | 32.5 | - | 20.0 | |
Cash and cash equivalents | 17.3 | 47.3 | 33.6 | |
181.8 | 177.2 | 153.9 | ||
Total assets | Â | 430.3 | 403.4 | 401.7 |
Current liabilities | Â | |||
Loans and other borrowings | 15 | 6.1 | - | - |
Trade and other payables | 86.9 | 90.7 | 70.3 | |
Derivative financial instruments | 14 | 0.5 | 0.3 | 0.3 |
Lease liabilities | 14 | 1.7 | 1.6 | 1.8 |
Provisions | 16 | 2.0 | 0.5 | 0.5 |
Current tax liabilities | - | 0.9 | 0.7 | |
97.2 | 94.0 | 73.6 | ||
Non-current liabilities | Â | |||
Deferred tax liabilities | 33.0 | 28.8 | 32.3 | |
Lease liabilities | 14 | 2.6 | 3.2 | 3.1 |
Derivative financial instruments | 14 | 0.1 | - | - |
35.7 | 32.0 | 35.4 | ||
Capital and reserves | ||||
Share capital | 4.7 | 4.7 | 4.7 | |
Share premium account | 0.9 | 0.9 | 0.9 | |
Share options reserve | 3.1 | 4.0 | 4.0 | |
Other reserves | (0.5) | (0.1) | (0.1) | |
Retained earnings | 289.2 | 267.9 | 283.2 | |
297.4 | 277.4 | 292.7 | ||
Total equity and liabilities | Â | 430.3 | 403.4 | 401.7 |
Â
Â
Consolidated Condensed Statement of Comprehensive Income | |||
 | Unaudited | Unaudited | Audited |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
£m | £m | £m | |
Profit for the period | 18.7 | 21.0 | 38.5 |
Other comprehensive (expense)/income | Â | ||
Items that will not be reclassified to profit or loss | Â | ||
Remeasurements on defined benefit pension plans (Note 17) | - | 0.7 | 0.7 |
Deferred tax movements on items above | - | (0.2) | (0.2) |
Items that will be or have been reclassified to profit or loss | Â | ||
Loss arising on cash flow hedges during the period | (0.6) | (0.3) | (0.3) |
Deferred tax movements on items above | 0.2 | 0.1 | 0.1 |
Other comprehensive (expense)/income for the period, net of tax | (0.4) | 0.3 | 0.3 |
Total comprehensive income attributable to equity holders of the parent | 18.3 | 21.3 | 38.8 |
Â
Â
Consolidated Condensed Statement of Changes in Equity (Unaudited) | ||||||
 | Share capital | Share premium account | Share options reserve | Other reserves | Retained earnings | Total |
 | £m | £m | £m | £m | £m | £m |
At 28 January 2024 | 4.7 | 0.9 | 4.0 | (0.1) | 283.2 | 292.7 |
Profit for the period | - | - | - | - | 18.7 | 18.7 |
Other comprehensive expense | - | - | - | (0.4) | - | (0.4) |
Total comprehensive (expense)/income for the period | - | - | - | (0.4) | 18.7 | 18.3 |
Company shares purchased for use by employee benefit trusts | - | - | - | - | (1.9) | (1.9) |
Proceeds on disposal of shares by employee benefit trusts | - | - | - | - | 0.7 | 0.7 |
Recognition of share-based payment costs | - | - | 1.4 | - | - | 1.4 |
Transfer of reserve on share award | - | - | (2.3) | - | 2.3 | - |
Dividends paid | - | - | - | - | (13.8) | (13.8) |
At 27 July 2024 | 4.7 | 0.9 | 3.1 | (0.5) | 289.2 | 297.4 |
 | Share capital | Share premium account | Share options reserve | Other reserves | Retained earnings | Total |
 | £m | £m | £m | £m | £m | £m |
At 29 January 2023 | 4.7 | 0.9 | 3.4 | 0.1 | 259.7 | 268.8 |
Profit for the period | - | - | - | - | 21.0 | 21.0 |
Other comprehensive (expense)/income | - | - | - | (0.2) | 0.5 | 0.3 |
Total comprehensive (expense)/income for the period | - | - | - | (0.2) | 21.5 | 21.3 |
Company shares purchased for use by employee benefit trusts | - | - | - | - | (2.6) | (2.6) |
Proceeds on disposal of shares by employee benefit trusts | - | - | - | - | 0.8 | 0.8 |
Recognition of share-based payment costs | - | - | 1.0 | - | - | 1.0 |
Transfer of reserve on share award | - | - | (0.3) | - | 0.3 | - |
Deferred tax on items taken direct to reserves | - | - | (0.1) | - | - | (0.1) |
Dividends paid | - | - | - | - | (11.8) | (11.8) |
At 30 July 2023 | 4.7 | 0.9 | 4.0 | (0.1) | 267.9 | 277.4 |
Â
Â
Consolidated Condensed Statement of Changes in Equity (Audited) | ||||||
 | Share capital | Share premium account | Share options reserve | Other reserves | Retained earnings | Total |
£m | £m | £m | £m | £m | £m | |
At 29 January 2023 | 4.7 | 0.9 | 3.4 | 0.1 | 259.7 | 268.8 |
Profit for the year | - | - | - | - | 38.5 | 38.5 |
Other comprehensive (expense)/income | - | - | - | (0.2) | 0.5 | 0.3 |
Total comprehensive (expense)/income for the year | - | - | - | (0.2) | 39.0 | 38.8 |
Company shares purchased for use by employee benefit trusts | - | - | - | - | (3.6) | (3.6) |
Proceeds on disposal of shares by employee benefit trusts | - | - | - | - | 1.3 | 1.3 |
Recognition of share-based payment costs | - | - | 2.1 | - | - | 2.1 |
Transfer of reserve on share award | - | - | (1.6) | - | 1.5 | (0.1) |
Deferred tax on items taken direct to reserves | - | - | 0.1 | - | - | 0.1 |
Dividends paid | - | - | - | - | (14.7) | (14.7) |
At 28 January 2024 | 4.7 | 0.9 | 4.0 | (0.1) | 283.2 | 292.7 |
Â
Â
Consolidated Condensed Cash Flow Statement | |||
 | Unaudited | Unaudited | Audited |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
£m | £m | £m | |
Operating activities | |||
Profit for the period before tax | 24.9 | 27.8 | 51.3 |
Adjustments for: | |||
Interest receivable | (0.8) | (0.7) | (1.4) |
Interest payable | 0.2 | 0.1 | 0.2 |
Impairment of investment in associate | - | 0.7 | 0.7 |
Write off of loans and receivables | - | 1.5 | 1.5 |
Contingent consideration | - | (0.8) | (0.8) |
Depreciation of property, plant and equipment | 5.8 | 5.4 | 11.2 |
Amortisation of intangible assets | 0.5 | 0.6 | 1.1 |
Share-based payment costs | 1.4 | 1.0 | 2.1 |
Impairment of assets classified as held for sale | 1.1 | - | - |
(Gain)/loss on sale of property, plant and equipment | (0.1) | 0.1 | (0.5) |
Operating cash flows before movements in working capital | 33.0 | 35.7 | 65.4 |
Decrease/(increase) in inventories | 0.9 | (1.3) | (1.8) |
Increase in receivables | (30.3) | (33.5) | (3.4) |
Increase in payables | 18.5 | 20.4 | - |
Difference between employer pension contributions and amounts recognised in the income statement | (2.9) | - | - |
Cash generated by operations | 19.2 | 21.3 | 60.2 |
Tax paid | (6.2) | (6.2) | (11.7) |
Net cash from operating activities | 13.0 | 15.1 | 48.5 |
Investing activities | Â | ||
Acquisition of subsidiary | - | - | (12.3) |
Purchase of property, plant and equipment | (7.4) | (6.5) | (17.8) |
Proceeds on sale of property, plant and equipment | 0.2 | - | 0.6 |
Funds placed on fixed term deposit | (37.5) | (25.0) | (20.0) |
Funds returned from fixed term deposit | 25.0 | 65.0 | 40.0 |
Interest received | 0.5 | 1.1 | 1.4 |
Net cash used in investing activities | (19.2) | 34.6 | (8.1) |
Financing activities | Â | ||
Loans made | - | 5.0 | 5.0 |
Loans repaid | - | (5.7) | (5.7) |
Lease payments | (1.1) | (1.0) | (1.9) |
Purchase of Company shares by employee benefit trusts | (1.9) | (2.6) | (3.6) |
Proceeds from disposal of Company shares by employee benefit trusts | 0.7 | 0.8 | 1.3 |
Dividends paid | (13.8) | (11.8) | (14.7) |
Interest paid | (0.1) | - | (0.1) |
Net cash used in financing activities | (16.2) | (15.3) | (19.7) |
Net (decrease)/increase in cash and cash equivalents | (22.4) | 34.4 | 20.7 |
Cash and cash equivalents at beginning of period | 33.6 | 12.9 | 12.9 |
Cash and cash equivalents at end of period | 11.2 | 47.3 | 33.6 |
Cash and cash equivalents per the cash flow statement comprises cash and cash equivalents per the statement of financial position of £17.3m, net of bank overdrafts of £6.1m for the period ended 27 July 2024. |
Â
Â
Notes to the Consolidated Condensed Financial Statements | |
1. General information |
Â
3. Accounting policies |
New standards and interpretations applied for the first time |
In the current year, the Group has applied a number of amendments to IFRS Accounting Standards issued by the International Accounting Standards Board (IASB) and endorsed for use in the UK which are mandatorily effective for accounting periods beginning on or after 29 January 2024. Apart from those changes to accounting policies noted below, the accounting policies applied in these condensed interim financial statements are the same as those applied in the most recent annual report for the year ended 28 January 2024. There has been no material impact on the amounts reported or disclosures required in these condensed interim financial statements. Â |
- Classification of Liabilities as Current or Non-current and Non-current liabilities with covenants - Amendments to IAS 1 |
- Lease liability in sale and leaseback - Amendments to IFRS 16 |
- Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7 |
Assets classified as held for sale |
Assets classified as held for sale are measured at the lower of the carrying amount and fair value less costs to sell where the assets meet the 'held for sale' criteria within IFRS 5. Depreciation on these assets ceases and they are presented within current assets in the balance sheet. |
4. Principal risks and uncertainties |
The directors consider that the following principal risks and uncertainties could have a material impact on the Group's performance in the balance of the financial year. Further detail can be found on pages 48 - 55 of the Group's annual financial statements as at 28 January 2024, which are available on our website, www.agbarr.co.uk. |
- Changes in consumer preferences, perception or purchasing behaviour |
- Consumer rejection of reformulated products |
- Loss of product integrity |
- Loss of continuity of supply of major raw materials |
- Adverse publicity in relation to the soft drinks industry, the Group or its brands |
- Government intervention on climate change and environmental issues e.g. packaging waste |
- Failure to maintain customer relationships or take account of changing market dynamics |
- Inability to protect the Group's intellectual property rights |
- Failure of the Group's operational infrastructure |
- Failure of critical IT systems or a breach of cyber security |
- Financial risks |
- Environmental Social and Governance (ESG) risks |
The Group has reviewed its exposure to climate-related and other emerging business risks but has not identified any specific risks that would impact the financial performance or position of the Group at 27 July 2024. |
5. Financial risk management and financial instruments |
The Group's activities expose it to a variety of financial risks: market risk (including foreign exchange risk, cash flow and fair value interest rate risk and price risk), credit risk and liquidity risk. |
Â
6. Segment reporting | Â | ||||
The Board and senior executives have been identified as the Group's chief operating decision-makers, who review the Group's internal reporting in order to assess performance and allocate resources. | Â | ||||
Unaudited | Â | ||||
Six months ended 27 July 2024 | Â | ||||
 | Soft drinks | Cocktail solutions | Other | Total | |
£m | £m | £m | £m | ||
Total revenue | 194.6 | 21.1 | 5.6 | 221.3 | |
Gross profit | 79.5 | 7.8 | 1.8 | 89.1 | |
Unaudited | Â | ||||
Six months ended 30 July 2023 | Â | ||||
Soft drinks | Cocktail solutions | Other | Total | ||
£m | £m | £m | £m | ||
Total revenue | 181.9 | 23.3 | 5.2 | 210.4 | |
Gross profit | 69.9 | 7.9 | 1.6 | 79.4 | |
Audited | Â | ||||
Year ended 28 January 2024 | Â | ||||
Soft drinks | Cocktail solutions | Other | Total | ||
£m | £m | £m | £m | ||
Total revenue | 346.6 | 42.9 | 10.5 | 400.0 | |
Gross profit | 135.6 | 15.4 | 3.2 | 154.2 | |
Â
 There are no material intersegment sales. All revenue is in relation to product sales, which is recognised at a point in time, upon delivery to the customer. |
Â
7. Seasonality of operations | |||
Revenues and reported profits are affected by weather conditions, cost inflation, the timing of marketing and promotional investment and innovation launches. Owing to the timing of the one-off costs related to the business change projects, reported profits for the second half of the year to 25 January 2025 are expected to be higher than those for the 26 weeks ended 27 July 2024. | |||
8. Operating profit | Â | ||
The following items have been charged/(credited) to operating profit during the period: | |||
Unaudited | Unaudited | Audited | |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
£m | £m | £m | |
Business change projects | 4.4 | - | - |
Provision for business reorganisation | 0.7 | - | - |
(Gain)/loss on sale of property, plant and equipment | (0.1) | 0.1 | - |
Â
 Included within the business change project costs is a £1.1m impairment charge against assets classified as held for sale (Note 13).  |
Â
9. Net finance costs | |||
 | Unaudited | Unaudited | Audited |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
Finance income | £m | £m | £m |
Interest receivable on short-term deposits | 0.7 | 0.6 | 1.3 |
Finance costs relating to defined benefit pension plans | 0.1 | 0.1 | 0.1 |
0.8 | 0.7 | 1.4 | |
Finance costs | £m | £m | £m |
Interest payable | 0.1 | - | 0.1 |
Lease interest | 0.1 | 0.1 | 0.1 |
0.2 | 0.1 | 0.2 |
Â
10. Tax on profit | |||
The interim period total tax charge of £6.2m (six months ended 30 July 2023: £6.8m; year ended 28 January 2024: £12.8m) is accrued based on the estimated annual effective tax rate of 24.9% (six months ended 30 July 2023: 24.5%; year ended 28 January 2024: 25.0%). The effective tax rate is calculated using the forecast year end effective corporation tax rate and the movement in deferred tax to 27 July 2024. The effective tax rate has remained relatively unchanged in the six months ended 27 July 2024 compared to the year ended 28 January 2024. | |||
Unaudited | Unaudited | Audited | |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
Analysis of tax charge | £m | £m | £m |
Current income tax charge | 5.3 | 6.4 | 11.7 |
Deferred income tax charge | 0.9 | 0.4 | 1.1 |
Total tax charge in the condensed income statement | 6.2 | 6.8 | 12.8 |
Â
11. Earnings per share | |||
Basic earnings per share has been calculated by dividing the earnings attributable to equity holders of the parent by the weighted average number of shares in issue during the year, excluding shares held by the employee share scheme trusts. | |||
Unaudited | Unaudited | Audited | |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
Profit attributable to equity holders of the Company (£m) | 18.7 | 21.0 | 38.5 |
Weighted average number of ordinary shares in issue | 110,797,643 | 111,288,517 | 111,289,068 |
Basic earnings per share (pence) | 16.88 | 18.87 | 34.59 |
 For diluted earnings per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all potentially dilutive ordinary shares. These represent share options granted to employees where the exercise price is less than the average market price of the Company's ordinary shares during the period. The number of shares calculated as above is compared with the number of shares that would have been issued assuming the exercise of the share options. | |||
Unaudited | Unaudited | Audited | |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
Profit attributable to equity holders of the Company (£m) | 18.7 | 21.0 | 38.5 |
Weighted average number of ordinary shares in issue | 110,797,643 | 111,288,517 | 111,289,068 |
Adjustment for dilutive effect of share options | 1,047,922 | 1,193,573 | 1,159,537 |
Diluted weighted average number of ordinary shares in issue | 111,845,565 | 112,482,090 | 112,448,605 |
Diluted earnings per share (pence) | 16.72 | 18.67 | 34.24 |
Â
12. Dividends | ||||||
 | Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 |
per share (p) | per share (p) | per share (p) | £m | £m | £m | |
Paid final dividend | 12.4 | 10.60 | 10.60 | 13.8 | 11.8 | 11.8 |
Paid interim dividend | - | - | 2.65 | - | - | 2.9 |
12.40 | 10.60 | 13.25 | 13.8 | 11.8 | 14.7 | |
An interim dividend of 3.10 pence per share was approved by the Board on 24 September 2024 and will be paid on 1 November 2024 to shareholders on the register as of 4 October 2024. | ||||||
Â
13. Assets classified as held for sale | |
Unaudited | £m |
Balance at 29 January 2023 and 28 January 2024 | - |
Net book value of assets transferred from property, plant and equipment | 3.2 |
Impairment charge | (1.1) |
Balance at 27 July 2024 | 2.1 |
The closure of the Barr Direct business resulted in a number of vehicles on the balance sheet with no estimated useful life. Following an assessment of fair value less costs to sell an impairment charge of £1.1m has been recognised. These assets are being actively marketed and a number have been sold since the period end. |
Â
14. Financial instruments | Â | |||
Current liabilities of £0.5m (at 30 July 2023 and 28 January 2024: £0.3m) relate to forward foreign currency contracts with a maturity of less than 12 months and are recognised at fair value through the cash flow hedge reserve, included within other reserves. | ||||
Carrying amount | ||||
Unaudited | Fair value - hedging instruments | Other financial assets at amortised cost | Other financial liabilities at amortised cost | Total |
At 27 July 2024 | £m | £m | £m | £m |
Financial assets - Current | ||||
Foreign exchange contracts used for hedging | - | - | - | - |
Trade receivables | - | 91.2 | - | 91.2 |
Short-term investments | - | 32.5 | - | 32.5 |
Cash and cash equivalents | - | 17.3 | - | 17.3 |
 | - | 141.0 | - | 141.0 |
Financial liabilities - Non-current | ||||
Foreign exchange contracts used for hedging | 0.1 | - | - | 0.1 |
Lease liabilities | - | - | 2.6 | 2.6 |
 | 0.1 | - | 2.6 | 2.7 |
Financial liabilities - Current | ||||
Bank overdraft | - | - | 6.1 | 6.1 |
Foreign exchange contracts used for hedging | 0.5 | - | - | 0.5 |
Lease liabilities | - | - | 1.7 | 1.7 |
Accruals | - | - | 37.0 | 37.0 |
Trade payables | - | - | 42.6 | 42.6 |
 | 0.5 | - | 87.4 | 87.9 |
 |
Â
Carrying amount | ||||
Unaudited | Fair value - hedging instruments | Other financial assets at amortised cost | Other financial liabilities at amortised cost | Total |
At 30 July 2023 | £m | £m | £m | £m |
Financial assets - Current | ||||
Foreign exchange contracts used for hedging | - | - | - | - |
Trade receivables | - | 93.9 | - | 93.9 |
Cash and cash equivalents | - | 47.3 | - | 47.3 |
- | 141.2 | - | 141.2 | |
Financial liabilities - Non-current | ||||
Lease liabilities | - | - | 3.2 | 3.2 |
- | - | 3.2 | 3.2 | |
Financial liabilities - Current | ||||
Foreign exchange contracts used for hedging | 0.3 | - | - | 0.3 |
Lease liabilities | - | - | 1.6 | 1.6 |
Trade payables | - | - | 90.7 | 90.7 |
0.3 | - | 92.3 | 92.6 | |
Carrying amount | ||||
Audited | Fair value - hedging instruments | Other financial assets at amortised cost | Other financial liabilities at amortised cost | Total |
At 28 January 2024 | £m | £m | £m | £m |
Financial assets - Current | ||||
Trade receivables | - | 59.8 | - | 59.8 |
Short-term investments | - | 20.0 | - | 20.0 |
Cash and cash equivalents | - | 33.6 | - | 33.6 |
- | 113.4 | - | 113.4 | |
Financial liabilities - Non-current | ||||
Lease liabilities | - | - | 3.1 | 3.1 |
- | - | 3.1 | 3.1 | |
Financial liabilities - Current | ||||
Foreign exchange contracts used for hedging | 0.3 | - | - | 0.3 |
Lease liabilities | - | - | 1.8 | 1.8 |
Accruals | - | - | 30.0 | 30.0 |
Trade payables | - | - | 36.1 | 36.1 |
0.3 | - | 67.9 | 68.2 | |
Â
15. Loans and other borrowings | |||
Movements in borrowings are analysed as follows: | |||
Unaudited | Unaudited | Audited | |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
£m | £m | £m | |
Opening borrowings balance | 4.9 | 5.8 | 5.8 |
Net lease movements | (0.6) | (0.3) | (0.2) |
Borrowings acquired/drawn-down | 6.1 | 5.0 | 5.0 |
Repayments of borrowings | - | (5.7) | (5.7) |
Closing borrowings balance | 10.4 | 4.8 | 4.9 |
The reconciliation of the above closing borrowings balance to the figures on the face of the consolidated condensed statement of financial position is as follows: | |||
Unaudited | Unaudited | Audited | |
As at 27 July 2024 | As at 30 July 2023 | As at 28 January 2024 | |
£m | £m | £m | |
Bank borrowings | 6.1 | - | - |
Lease liabilities | 4.3 | 4.8 | 4.9 |
Total borrowings and loans | 10.4 | 4.8 | 4.9 |
Disclosed as: | |||
Current liabilities | 7.8 | 1.6 | 1.8 |
Non-current liabilities | 2.6 | 3.2 | 3.1 |
The reconciliation to net debt is as follows: | |||
Unaudited | Unaudited | Audited | |
As at 27 July 2024 | As at 30 July 2023 | As at 28 January 2024 | |
£m | £m | £m | |
Closing borrowings balance | (10.4) | (4.8) | (4.9) |
Short-term investments | 32.5 | - | 20.0 |
Cash and cash equivalents | 17.3 | 47.3 | 33.6 |
Net funds | 39.4 | 42.5 | 48.7 |
In July 2024, the Group agreed a £15m overdraft facility with the Royal Bank of Scotland. This will support intra-month working capital requirements and maximise cash deposit interest. | |||
The drawn/undrawn facilities at 27 July 2024 are as follows: | |||
Total facility | Drawn | Undrawn | |
£m | £m | £m | |
Revolving credit facility - five years, expires February 2026 | 20.0 | - | 20.0 |
Overdraft facility | 15.0 | 6.1 | 8.9 |
 | 35.0 | 6.1 | 28.9 |
 |
Â
16. Provisions | |||||
 | Business change projects | Business reorganisation | Customer related provisions | Repairs/ | Total |
Unaudited | £m | £m | £m | £m | £m |
Opening provision at 29 January 2023 | - | 0.3 | 0.1 | 0.4 | 0.8 |
Provision utilised during the year | - | (0.3) | - | - | (0.3) |
Closing provision at 28 January 2024 | - | - | 0.1 | 0.4 | 0.5 |
Provision created during the year | 3.3 | 0.7 | - | - | 4.0 |
Provision utilised during the year | (2.5) | - | - | - | (2.5) |
Closing provision at 27 July 2024 | 0.8 | 0.7 | 0.1 | 0.4 | 2.0 |
 The business change projects provision relates to the costs associated with two projects. Firstly, the closure of the Barr Direct operation and the move to larger field sales team, supplying brands through existing wholesale channels which completed in June. Secondly, the integration of the Boost business into Barr Soft Drinks. This will result in a reduction in duplicated activities and access to the wider Barr Soft Drinks sales channels and organisation and also the closure of the Boost Leeds office. This is expected to complete by the end of the year ending 25 January 2025. |
Â
17. Retirement benefit obligations | |||
On 1 May 2016 the A.G. BARR p.l.c. (2008) Pension and Life Assurance Scheme was closed to future accrual following a negotiated agreement between the Company and the board of trustees. | |||
Unaudited | Unaudited | Audited | |
Six months ended 27 July 2024 | Six months ended 30 July 2023 | Year ended 28 January 2024 | |
£m | £m | £m | |
Opening present value of obligation | (69.3) | (76.9) | (76.9) |
Interest expense | (1.6) | (1.6) | (3.3) |
Remeasurement - changes in financial assumptions | (0.5) | 6.2 | 6.7 |
Benefits paid | 1.7 | 1.9 | 4.2 |
Closing present value of obligation | (69.7) | (70.4) | (69.3) |
Opening fair value of plan assets | 72.5 | 79.3 | 79.3 |
Interest income | 1.7 | 1.7 | 3.4 |
Remeasurement - actuarial return on assets | 0.5 | (5.5) | (6.0) |
Employer contributions | 2.9 | - | - |
Benefits paid | (1.7) | (1.9) | (4.2) |
Closing fair value of plan assets | 75.9 | 73.6 | 72.5 |
As at 27 July 2024 | As at 30 July 2023 | As at 28 January 2024 | |
£m | £m | £m | |
Present value of funded obligations | (69.7) | (70.4) | (69.3) |
Fair value of plan assets | 75.9 | 73.6 | 72.5 |
Surplus recognised under IAS 19 | 6.2 | 3.2 | 3.2 |
The key financial assumptions used to value the liabilities were as follows: | |||
As at 27 July 2024 | As at 30 July 2023 | As at 28 January 2024 | |
% | % | % | |
Discount rate | 5.1 | 5.2 | 5.0 |
Inflation assumption | 3.2 | 3.2 | 3.1 |
Â
18. Movements in own shares held by employee benefit trusts | |||
During the six months to 27 July 2024 the employee benefit trusts of the Group acquired 338,003 (six months to 30 July 2023: 520,218; year to 28 January 2024: 732,524) of the Company's shares. The total amount paid to acquire the shares has been deducted from shareholders' equity and is included within retained earnings.  At 27 July 2024 the shares held by the Company's employee benefit trusts represented 793,306 (30 July 2023: 1,187,730; 28 January 2024: 1,048,677) shares at a purchased cost of £4.1m (30 July 2023: £6.6m; 28 January 2024: £5.4m). | |||
19. Contingencies and commitments | |||
 | Unaudited | Unaudited | Audited |
As at 27 July 2024 | As at 30 July 2023 | As at 28 January 2024 | |
£m | £m | £m | |
Commitments for the acquisition of property, plant and equipment | 2.5 | 7.7 | 8.7 |
20. Related party transactions | Â | ||
There have been no related party transactions in the first 26 weeks of the current financial year which have materially affected the financial position or performance of the Group. |
Â
RESPONSIBILITY AND CAUTIONARY STATEMENTS | |
Responsibility Statement | |
Company law requires the directors to prepare statements for each financial year. Under that law the directors are required to prepare group financial statements in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and UK-adopted International Financial Reporting Standards. | |
Euan Sutherland | Stuart Lorimer |
Chief Executive | Finance Director |
24 September 2024 | 24 September 2024 |
Â
Glossary
Non-GAAP measures are provided because they are tracked by management to assess the Group's operating performance and to inform financial, strategic and operating decisions.
Adjusting items
The Group excludes adjusting items from its non-GAAP measures because of their size, frequency and nature to allow shareholders to understand better the elements of financial performance in the period, so as to facilitate comparison with prior periods and to assess trends in financial performance more readily. These items are primarily non-operational.
Definitions of non-GAAP measures used are provided below:
Capital expenditure is a non-GAAP measure and is defined as the cash purchases of property, plant and equipment and is disclosed in the consolidated condensed cash flow statement.
Adjusted profit attributable to equity holders is a non-GAAP measure calculated as adjusted profit attributable to equity holders.
Operating margin (adjusted) is a non-GAAP measure calculated by dividing adjusted operating profit by revenue.
Profit before tax (adjusted) is a non-GAAP measure calculated as reported profit before tax after adjusting items.
Basic EPS (adjusted) is a non-GAAP measure calculated by dividing adjusted profit attributable to equity holders by the weighted average number of shares in issue.
Â
Reconciliation of Non-GAAP measures | ||||||||||||
Adjusted Consolidated Income Statements  | ||||||||||||
 | Six months ended 27 July 2024 |  | Six months ended 30 July 2023 | Year ended 28 January 2024 | ||||||||
Reported | Business change projects | Adjusted | Â | Reported | Boost earn-out accrual write back | Adjusted | Reported | Boost earn-out accrual write back | Adjusted | |||
£m | £m | £m |  | £m | £m | £m | £m | £m | £m | |||
Revenue | 221.3 | - | 221.3 | Â | 210.4 | - | 210.4 | 400.0 | - | 400.0 | ||
Cost of sales | (132.2) | - | (132.2) | Â | (131.0) | - | (131.0) | (245.8) | - | (245.8) | ||
Gross profit | 89.1 | - | 89.1 | Â | 79.4 | - | 79.4 | 154.2 | - | 154.2 | ||
Operating expenses | (64.8) | 4.4 | (60.4) | Â | (52.2) | (0.8) | (53.0) | (104.1) | (0.8) | (104.9) | ||
Operating profit | 24.3 | 4.4 | 28.7 | Â | 27.2 | (0.8) | 26.4 | 50.1 | (0.8) | 49.3 | ||
Finance income | 0.8 | - | 0.8 | Â | 0.7 | - | 0.7 | 1.4 | - | 1.4 | ||
Finance costs | (0.2) | - | (0.2) | Â | (0.1) | - | (0.1) | (0.2) | - | (0.2) | ||
Profit before tax | 24.9 | 4.4 | 29.3 | Â | 27.8 | (0.8) | 27.0 | 51.3 | (0.8) | 50.5 | ||
Tax on profit | (6.2) | (1.1) | (7.3) | Â | (6.8) | - | (6.8) | (12.8) | - | (12.8) | ||
Profit for the period | 18.7 | 3.3 | 22.0 | Â | 21.0 | (0.8) | 20.2 | 38.5 | (0.8) | 37.7 | ||
Adjusting entries: | ||||||||||||
Â
Â
Operating margin (adjusted) | Six months ended 27 July 2024 £m |  | Six months ended 30 July 2023 £m | Year ended 28 January 2024 £m | |||||||
Revenue | 221.3 | Â | 210.4 | 400.0 | |||||||
Adjusted operating profit | 28.7 | Â | 26.4 | 49.3 | |||||||
Operating margin (adjusted) | 13.0% | Â | 12.5% | 12.3% | |||||||
Net cash at bank | £m |  | £m | £m | |||||||
Cash and cash equivalents | 17.3 | Â | 47.3 | 33.6 | |||||||
Short-term investments | 32.5 | Â | - | 20.0 | |||||||
Bank overdraft | (6.1) | Â | - | - | |||||||
Net cash at bank | 43.7 | Â | 47.3 | 53.6 | |||||||
Basic EPS (adjusted) | Â | ||||||||||
Adjusted profit attributable to equity shareholders of the Company £m | 22.0 | 20.2 | 37.7 | ||||||||
Weighted average number of ordinary shares in issue | 110,797,643 | 111,288,517 | 111,289,068 | ||||||||
Basic EPS (adjusted) | 19.86p | Â | 18.15p | 33.88p | |||||||
Â
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.